Market Introduction
Over the counter (OTC) drugs are available for the public for their general use. These drugs do not require a prescription from a physician. OTC medicines are available for various medical symptoms due to medical conditions such as coughs and colds, diarrhea, heartburn, constipation, acne, pain, and others. On the other hand, dietary supplements are available over the counter for fitness purposes. Whereas, in some cases, when a person is critically ill or requires treatment, then buying a dietary supplement with medicinal ingredients requires a prescription from a physician. These OTC drugs and nutritional supplements have two type, such as branded or generic.
Market Overview and Dynamics
The Asia PacificOTC Drug and Dietary Supplementmarketis expected to reach US$ 96,156.8 million in 2027 from US$ 55,157.2 million in 2019. The market is anticipated to grow with a CAGR of 7.3% from 2020 to 2027. Factors driving the market growth include rising awareness among population about general health issues, and advantages of OTC drugs are expected to propel the growth of the market. However, stringent government regulation for OTC drugs is the major factor hindering the market growth. COVID19 has affected the Asia Pacific countries which has led to high number of coronavirus cases. People are purchasing more immunity booster products available in the market to combat coronavirus effect
Key Market Segments
In terms of product, the analgesicssegment held the largest share of the market in 2019; however, the vitamins and dietary supplementssegment is anticipated to register the highest CAGR in the market during the forecast period. In terms of type, the generic segment held a larger share of the market in 2019and similarsegment is estimated to register a higher market sharein the market during the forecast period. Likewise, in terms of form, the in tabletssegment held a larger share of the market in 2019 and is estimated to register a higher CAGR in the market during the forecast period. In terms of distribution channel hospital and retail pharmacies held the largest share of market in 2019: however, the online channels segment is anticipated to register the highest CAGR in the market during forecast period.
Major Sources and Companies Listed
The World Health Organization (WHO), World Heart Federation, National Center for Biotechnology Information Therapeutic Goods Administration are some of the major primary and secondary sources for the Asia PacificOTC drug and dietary supplement market included in the report.
Reasons to buy the report
Asia Pacific OTC Drug and Dietary Supplement Market Segmentation
OTC drug and Dietary Supplement– By Product
OTC Drug and Dietary Supplement – By Type
OTC Drug and Dietary Supplement – By Form
OTC Drug and Dietary Supplement – By Distribution Channel
By Country
CompanyProfiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 55,157.2 Million |
| Market Size by 2027 | US$ 96,156.8 Million |
| CAGR (2020 - 2027) | 7.3% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific OTC Drug and Dietary Supplement Market is valued at US$ 55,157.2 Million in 2019, it is projected to reach US$ 96,156.8 Million by 2027.
As per our report Asia Pacific OTC Drug and Dietary Supplement Market, the market size is valued at US$ 55,157.2 Million in 2019, projecting it to reach US$ 96,156.8 Million by 2027. This translates to a CAGR of approximately 7.3% during the forecast period.
The Asia Pacific OTC Drug and Dietary Supplement Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific OTC Drug and Dietary Supplement Market report:
The Asia Pacific OTC Drug and Dietary Supplement Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific OTC Drug and Dietary Supplement Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific OTC Drug and Dietary Supplement Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific OTC Drug and Dietary Supplement Market
